Literature DB >> 36268197

Association Between Triglyceride-Glucose Index and Risk of Metabolic Dysfunction-Associated Fatty Liver Disease: A Cohort Study.

Ru Zhang1, Qing Guan1, Mengting Zhang1, Yajie Ding1, Zongzhe Tang1, Hongliang Wang2, Wei Zhang3, Yue Chen1, Rong Jiang1, Yan Cui1, Jie Wang1.   

Abstract

Objective: Insulin resistance (IR) is a major factor involved in the pathogenesis of metabolic dysfunction-associated fatty liver disease (MAFLD). Triglyceride-glucose (TyG) index, an easily detected surrogate marker of IR, has not been explored sufficiently on its relationship with incident MAFLD risk. This study sought to investigate the association of baseline TyG index with the risk of MAFLD in a Chinese cohort.
Methods: This health check-up cohort was constructed with eligible 2056 Chinese from a community. The TyG index was calculated as ln (fasting triglyceride [mg/dL]×fasting glucose [mg/dL]/2). Cox proportion hazard models were used to evaluate the longitudinal association between baseline TyG index and the risk of MAFLD.
Results: During an average follow-up of 2.5 ± 0.5 years, about 12.8% of the subjects developed MAFLD, and the incidence of MAFLD trended to increase with the quartile TyG index (P trend < 0.05). After adjusting for all confounders, TyG index was independently correlated with the risk of incident MAFLD (HR = 1.784, 95% CI = 1.383-2.302, P < 0.001), and the risk of MAFLD in the highest quartile of TyG index was two times higher than that in the lowest quartile (95% CI = 1.377-2.992, P = 0.001). The restricted cubic spline analysis showed that the relationship between TyG index and the risk of MAFLD was linear in males (P for total < 0.001; P for non-linearity = 0.746), but nonlinear in females (P for non-linearity = 0.040).
Conclusion: A high baseline TyG index was independently associated with a high risk of incident MAFLD, and we might develop the strategy of MAFLD prevention based on the TyG index.
© 2022 Zhang et al.

Entities:  

Keywords:  cohort study; insulin resistance; metabolic dysfunction-associated fatty liver disease; risk; triglyceride-glucose index

Year:  2022        PMID: 36268197      PMCID: PMC9578360          DOI: 10.2147/DMSO.S383907

Source DB:  PubMed          Journal:  Diabetes Metab Syndr Obes        ISSN: 1178-7007            Impact factor:   3.249


  42 in total

1.  Nonalcoholic fatty liver disease incidence and impact on metabolic burden and death: A 20 year-community study.

Authors:  Alina M Allen; Terry M Therneau; Joseph J Larson; Alexandra Coward; Virend K Somers; Patrick S Kamath
Journal:  Hepatology       Date:  2018-03-23       Impact factor: 17.425

2.  Triglyceride glucose index as a surrogate measure of insulin sensitivity in obese adolescents with normoglycemia, prediabetes, and type 2 diabetes mellitus: comparison with the hyperinsulinemic-euglycemic clamp.

Authors:  Noor Shafina Mohd Nor; SoJung Lee; Fida Bacha; Hala Tfayli; Silva Arslanian
Journal:  Pediatr Diabetes       Date:  2015-08-06       Impact factor: 4.866

Review 3.  Epidemiological Features of NAFLD From 1999 to 2018 in China.

Authors:  Jianghua Zhou; Feng Zhou; Wenxin Wang; Xiao-Jing Zhang; Yan-Xiao Ji; Peng Zhang; Zhi-Gang She; Lihua Zhu; Jingjing Cai; Hongliang Li
Journal:  Hepatology       Date:  2020-05       Impact factor: 17.425

4.  Metabolically Healthy Obesity and the Development of Nonalcoholic Fatty Liver Disease.

Authors:  Yoosoo Chang; Hyun-Suk Jung; Juhee Cho; Yiyi Zhang; Kyung Eun Yun; Mariana Lazo; Roberto Pastor-Barriuso; Jiin Ahn; Chan-Won Kim; Sanjay Rampal; Miguel Cainzos-Achirica; Di Zhao; Eun Cheol Chung; Hocheol Shin; Eliseo Guallar; Seungho Ryu
Journal:  Am J Gastroenterol       Date:  2016-05-17       Impact factor: 10.864

5.  Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance.

Authors:  Tingting Du; Gang Yuan; Muxun Zhang; Xinrong Zhou; Xingxing Sun; Xuefeng Yu
Journal:  Cardiovasc Diabetol       Date:  2014-10-20       Impact factor: 9.951

6.  Triglyceride Glucose Index Is Superior to the Homeostasis Model Assessment of Insulin Resistance for Predicting Nonalcoholic Fatty Liver Disease in Korean Adults.

Authors:  Sang Bae Lee; Min Kyung Kim; Shinae Kang; Kahui Park; Jung Hye Kim; Su Jung Baik; Ji Sun Nam; Chul Woo Ahn; Jong Suk Park
Journal:  Endocrinol Metab (Seoul)       Date:  2019-06

7.  The Triglyceride and Glucose Index Is a Predictor of Incident Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study.

Authors:  Aya Kitae; Yoshitaka Hashimoto; Masahide Hamaguchi; Akihiro Obora; Takao Kojima; Michiaki Fukui
Journal:  Can J Gastroenterol Hepatol       Date:  2019-10-07

8.  Comparison of several blood lipid-related indexes in the screening of non-alcoholic fatty liver disease in women: a cross-sectional study in the Pearl River Delta region of southern China.

Authors:  Jingrui Wang; Zhenzhen Su; Yijin Feng; Ruihan Xi; Jiamin Liu; Peixi Wang
Journal:  BMC Gastroenterol       Date:  2021-12-19       Impact factor: 3.067

9.  A longitudinal epidemiological study on the triglyceride and glucose index and the incident nonalcoholic fatty liver disease.

Authors:  Rongjiong Zheng; Zhennan Du; Mingming Wang; Yushan Mao; Wenjie Mao
Journal:  Lipids Health Dis       Date:  2018-11-20       Impact factor: 3.876

10.  Association Between the Triglyceride-Glucose Index and Outcomes of Nonalcoholic Fatty Liver Disease: A Large-Scale Health Management Cohort Study.

Authors:  Jing Liu; Liying Guan; Meng Zhao; Qihang Li; An Song; Ling Gao; Haiyan Lin; Jiajun Zhao
Journal:  Diabetes Metab Syndr Obes       Date:  2021-06-21       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.